日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/12 | 3,118 | 3,168 | 3,095 | 3,166 | +26 | +0.8% | 454,100 |
| 2024/06/11 | 3,080 | 3,154 | 3,073 | 3,140 | -8 | -0.3% | 436,700 |
| 2024/06/10 | 3,118 | 3,175 | 3,115 | 3,148 | +50 | +1.6% | 408,100 |
| 2024/06/07 | 3,045 | 3,104 | 3,037 | 3,098 | +53 | +1.7% | 434,400 |
| 2024/06/06 | 3,055 | 3,081 | 3,027 | 3,045 | -38 | -1.2% | 798,800 |
| 2024/06/05 | 3,065 | 3,103 | 3,050 | 3,083 | -58 | -1.8% | 813,500 |
| 2024/06/04 | 3,100 | 3,141 | 3,040 | 3,141 | +5 | +0.2% | 723,600 |
| 2024/06/03 | 3,195 | 3,247 | 3,107 | 3,136 | +63 | +2.1% | 1,230,600 |
| 2024/05/31 | 2,912 | 3,079 | 2,902 | 3,073 | +173.5 | +6% | 1,280,500 |
| 2024/05/30 | 2,755 | 2,899.5 | 2,733 | 2,899.5 | +110.5 | +4% | 1,701,300 |
| 2024/05/29 | 2,842 | 2,842 | 2,694 | 2,789 | -85 | -3% | 3,106,700 |
| 2024/05/28 | 2,874 | 2,874 | 2,874 | 2,874 | -700 | -19.6% | 337,500 |
| 2024/05/27 | 3,544 | 3,574 | 3,511 | 3,574 | +56 | +1.6% | 279,000 |
| 2024/05/24 | 3,554 | 3,583 | 3,512 | 3,518 | -40 | -1.1% | 457,700 |
| 2024/05/23 | 3,582 | 3,582 | 3,512 | 3,558 | +1 | ±0% | 525,600 |
| 2024/05/22 | 3,600 | 3,606 | 3,537 | 3,557 | -77 | -2.1% | 712,900 |
| 2024/05/21 | 3,685 | 3,707 | 3,632 | 3,634 | -59 | -1.6% | 429,400 |
| 2024/05/20 | 3,657 | 3,727 | 3,645 | 3,693 | -5 | -0.1% | 422,200 |
| 2024/05/17 | 3,650 | 3,719 | 3,626 | 3,698 | +23 | +0.6% | 511,000 |
| 2024/05/16 | 3,714 | 3,716 | 3,629 | 3,675 | -55 | -1.5% | 688,700 |
| 2024/05/15 | 3,900 | 3,912 | 3,718 | 3,730 | -150 | -3.9% | 896,200 |
| 2024/05/14 | 3,893 | 3,923 | 3,873 | 3,880 | -13 | -0.3% | 502,400 |
| 2024/05/13 | 3,981 | 4,024 | 3,864 | 3,893 | -530 | -12% | 1,076,000 |
| 2024/05/10 | 4,458 | 4,475 | 4,404 | 4,423 | +10 | +0.2% | 270,000 |
| 2024/05/09 | 4,383 | 4,460 | 4,378 | 4,413 | ±0 | ±0% | 247,900 |
| 2024/05/08 | 4,400 | 4,439 | 4,373 | 4,413 | +27 | +0.6% | 272,100 |
| 2024/05/07 | 4,423 | 4,460 | 4,385 | 4,386 | -3 | -0.1% | 270,300 |
| 2024/05/02 | 4,455 | 4,468 | 4,345 | 4,389 | -28 | -0.6% | 435,400 |
| 2024/05/01 | 4,384 | 4,455 | 4,376 | 4,417 | +53 | +1.2% | 199,300 |
| 2024/04/30 | 4,351 | 4,369 | 4,305 | 4,364 | +29 | +0.7% | 195,800 |
| 2024/04/26 | 4,271 | 4,348 | 4,240 | 4,335 | +28 | +0.7% | 176,200 |
| 2024/04/25 | 4,320 | 4,351 | 4,300 | 4,307 | +11 | +0.3% | 170,400 |
| 2024/04/24 | 4,327 | 4,343 | 4,296 | 4,296 | +1 | ±0% | 209,600 |
| 2024/04/23 | 4,288 | 4,330 | 4,269 | 4,295 | +7 | +0.2% | 159,000 |
| 2024/04/22 | 4,257 | 4,295 | 4,235 | 4,288 | +83 | +2% | 225,000 |
| 2024/04/19 | 4,240 | 4,249 | 4,182 | 4,205 | -39 | -0.9% | 230,400 |
| 2024/04/18 | 4,275 | 4,301 | 4,243 | 4,244 | -41 | -1% | 234,500 |
| 2024/04/17 | 4,335 | 4,339 | 4,272 | 4,285 | -51 | -1.2% | 209,000 |
| 2024/04/16 | 4,263 | 4,340 | 4,240 | 4,336 | +56 | +1.3% | 225,900 |
| 2024/04/15 | 4,300 | 4,311 | 4,263 | 4,280 | -59 | -1.4% | 170,700 |
| 2024/04/12 | 4,247 | 4,341 | 4,245 | 4,339 | +84 | +2% | 278,100 |
| 2024/04/11 | 4,326 | 4,326 | 4,247 | 4,255 | -79 | -1.8% | 413,100 |
| 2024/04/10 | 4,322 | 4,372 | 4,321 | 4,334 | -2 | ±0% | 136,700 |
| 2024/04/09 | 4,341 | 4,363 | 4,297 | 4,336 | -26 | -0.6% | 221,800 |
| 2024/04/08 | 4,375 | 4,378 | 4,339 | 4,362 | -10 | -0.2% | 167,700 |
| 2024/04/05 | 4,311 | 4,372 | 4,300 | 4,372 | +40 | +0.9% | 306,800 |
| 2024/04/04 | 4,333 | 4,348 | 4,302 | 4,332 | +14 | +0.3% | 247,900 |
| 2024/04/03 | 4,301 | 4,353 | 4,267 | 4,318 | +3 | +0.1% | 354,600 |
| 2024/04/02 | 4,397 | 4,402 | 4,287 | 4,315 | -102 | -2.3% | 465,200 |
| 2024/04/01 | 4,480 | 4,484 | 4,415 | 4,417 | -53 | -1.2% | 260,200 |
251～
300
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 340,000円 | +8.0% | -15.3% | 3.65% | 9.55倍 | 0.93倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 412,500円 | +5.8% | +1.2% | 2.91% | 13.68倍 | 1.09倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 334,900円 | +3.8% | -19.9% | 4.06% | 10.88倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 186,400円 | +5.9% | +684.6% | 2.95% | 12.37倍 | 1.24倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 163,300円 | +5.0% | +1.5% | 0.00% | 13.97倍 | 3.72倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
